183 related articles for article (PubMed ID: 33503843)
1. Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2
Fattori S; Gorvel L; Granjeaud S; Rochigneux P; Rouvière MS; Ben Amara A; Boucherit N; Paul M; Dauplat MM; Thomassin-Piana J; Paciencia-Gros M; Avenin M; Pakradouni J; Barrou J; Charafe-Jauffret E; Houvenaeghel G; Lambaudie E; Bertucci F; Goncalves A; Tarpin C; Nunès JA; Devillier R; Chretien AS; Olive D
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33503843
[TBL] [Abstract][Full Text] [Related]
2. Exhausted intratumoral Vδ2
Rancan C; Arias-Badia M; Dogra P; Chen B; Aran D; Yang H; Luong D; Ilano A; Li J; Chang H; Kwek SS; Zhang L; Lanier LL; Meng MV; Farber DL; Fong L
Nat Immunol; 2023 Apr; 24(4):612-624. PubMed ID: 36928415
[TBL] [Abstract][Full Text] [Related]
3. Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
Nguyen S; Chevalier MF; Benmerzoug S; Cesson V; Schneider AK; Rodrigues-Dias SC; Dartiguenave F; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002184
[No Abstract] [Full Text] [Related]
4. Phenotypic Changes of Peripheral γδ T Cell and Its Subsets in Patients With Coronary Artery Disease.
Li Y; Jiang S; Li J; Yin M; Yan F; Chen Y; Chen Y; Wu T; Cheng M; He Y; Liang H; Yu H; Qiao Q; Guo Z; Xu Y; Zhang Y; Xiang Z; Yin Z
Front Immunol; 2022; 13():900334. PubMed ID: 35874761
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II.
Wistuba-Hamprecht K; Haehnel K; Janssen N; Demuth I; Pawelec G
Immun Ageing; 2015; 12():25. PubMed ID: 26640505
[TBL] [Abstract][Full Text] [Related]
7. Suppressive activity of Vδ2
Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
[TBL] [Abstract][Full Text] [Related]
8. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
[TBL] [Abstract][Full Text] [Related]
9. Association of Decreased Percentage of Vδ2
Maimaitijiang G; Shinoda K; Nakamura Y; Masaki K; Matsushita T; Isobe N; Yamasaki R; Yoshikai Y; Kira JI
Front Immunol; 2018; 9():748. PubMed ID: 29692781
[TBL] [Abstract][Full Text] [Related]
10. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection alters phenotypes of different γδ T-cell subsets in renal transplant recipients with long-term stable graft function.
Lee S; Affandi JS; Irish AB; Price P
J Med Virol; 2017 Aug; 89(8):1442-1452. PubMed ID: 28198539
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of Vδ2
Bhatnagar N; Girard PM; Lopez-Gonzalez M; Didier C; Collias L; Jung C; Bollens D; Duvivier C; Von Platen C; Scott-Algara D; Weiss L;
Front Immunol; 2017; 8():1189. PubMed ID: 28993778
[TBL] [Abstract][Full Text] [Related]
13. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
14. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
15. Decreased Vδ2 γδ T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B.
Wu X; Zhang JY; Huang A; Li YY; Zhang S; Wei J; Xia S; Wan Y; Chen W; Zhang Z; Li Y; Wen T; Chen Y; Tanaka Y; Cao Y; Wang P; Zhao L; Wu Z; Wang FS; Yin Z
J Infect Dis; 2013 Oct; 208(8):1294-304. PubMed ID: 23847059
[TBL] [Abstract][Full Text] [Related]
16. Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing.
Hudecek R; Kohlova B; Siskova I; Piskacek M; Knight A
Front Immunol; 2021; 12():752646. PubMed ID: 34691070
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
Negash M; Tsegaye A; Wassie L; Howe R
BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy.
Wang L; Li J; Jiang S; Li Y; Guo R; Chen Y; Chen Y; Yu H; Qiao Q; Zhan M; Yin Z; Xiang Z; Xu C; Xu Y
Front Immunol; 2022; 13():900556. PubMed ID: 36311780
[TBL] [Abstract][Full Text] [Related]
19. Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
Kabelitz D; Kalyan S; Oberg HH; Wesch D
Oncoimmunology; 2013 Mar; 2(3):e23304. PubMed ID: 23802074
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells.
Sacchi A; Tumino N; Sabatini A; Cimini E; Casetti R; Bordoni V; Grassi G; Agrati C
Front Immunol; 2018; 9():1271. PubMed ID: 29928279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
